Selected research
Industry Research
Bacillus Licheniformis Live Bacteria Capsule Industry Research Report 2026
Market perspective
The global Bacillus Licheniformis Live Bacteria Capsule market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bacillus Licheniformis Live Bacteria Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bacillus Licheniformis Live Bacteria Capsule is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bacillus Licheniformis Live Bacteria Capsule is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bacillus Licheniformis Live Bacteria Capsule include Zhejiang Jingxin Pharmaceutical, Takeda Pharmaceuticals, Northeast Pharmaceutical Group, Novonesis, Hanmi Pharmaceutical and BMI KOREA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bacillus Licheniformis Live Bacteria Capsule market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bacillus Licheniformis Live Bacteria Capsule Market by Company
Zhejiang Jingxin Pharmaceutical
Takeda Pharmaceuticals
Northeast Pharmaceutical Group
Novonesis
Hanmi Pharmaceutical
BMI KOREA
Bacillus Licheniformis Live Bacteria Capsule Segment by Type
0.25g/Capsule
0.50g/Capsule
Bacillus Licheniformis Live Bacteria Capsule Segment by Application
Hospital
Clinic
Household Use
Bacillus Licheniformis Live Bacteria Capsule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacillus Licheniformis Live Bacteria Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacillus Licheniformis Live Bacteria Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacillus Licheniformis Live Bacteria Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bacillus Licheniformis Live Bacteria Capsule manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bacillus Licheniformis Live Bacteria Capsule by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bacillus Licheniformis Live Bacteria Capsule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.25g/Capsule
- 0.50g/Capsule
Applications
- Hospital
- Clinic
- Household Use
Companies covered
- Zhejiang Jingxin Pharmaceutical
- Takeda Pharmaceuticals
- Northeast Pharmaceutical Group
- Novonesis
- Hanmi Pharmaceutical
- BMI KOREA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bacillus Licheniformis Live Bacteria Capsule Market Size (2021-2032)
- 2.2.2 Global Bacillus Licheniformis Live Bacteria Capsule Sales (2021-2032)
- 2.2.3 Global Bacillus Licheniformis Live Bacteria Capsule Market Average Price (2021-2032)
- 2.3 Bacillus Licheniformis Live Bacteria Capsule by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.25g/Capsule
- 2.3.3 0.50g/Capsule
- 2.4 Bacillus Licheniformis Live Bacteria Capsule by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Household Use
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bacillus Licheniformis Live Bacteria Capsule Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bacillus Licheniformis Live Bacteria Capsule Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Bacillus Licheniformis Live Bacteria Capsule Revenue of Manufacturers (2021-2026)
- 3.4 Global Bacillus Licheniformis Live Bacteria Capsule Average Price by Manufacturers (2021-2026)
- 3.5 Global Bacillus Licheniformis Live Bacteria Capsule Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bacillus Licheniformis Live Bacteria Capsule, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bacillus Licheniformis Live Bacteria Capsule, Product Type & Application
- 3.8 Global Manufacturers of Bacillus Licheniformis Live Bacteria Capsule, Established Date
- 3.9 Global Bacillus Licheniformis Live Bacteria Capsule Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Jingxin Pharmaceutical
- 4.1.1 Zhejiang Jingxin Pharmaceutical Company Information
- 4.1.2 Zhejiang Jingxin Pharmaceutical Business Overview
- 4.1.3 Zhejiang Jingxin Pharmaceutical Bacillus Licheniformis Live Bacteria Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Jingxin Pharmaceutical Bacillus Licheniformis Live Bacteria Capsule Product Portfolio
- 4.1.5 Zhejiang Jingxin Pharmaceutical Recent Developments
- 4.2 Takeda Pharmaceuticals
- 4.2.1 Takeda Pharmaceuticals Company Information
- 4.2.2 Takeda Pharmaceuticals Business Overview
- 4.2.3 Takeda Pharmaceuticals Bacillus Licheniformis Live Bacteria Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Takeda Pharmaceuticals Bacillus Licheniformis Live Bacteria Capsule Product Portfolio
- 4.2.5 Takeda Pharmaceuticals Recent Developments
- 4.3 Northeast Pharmaceutical Group
- 4.3.1 Northeast Pharmaceutical Group Company Information
- 4.3.2 Northeast Pharmaceutical Group Business Overview
- 4.3.3 Northeast Pharmaceutical Group Bacillus Licheniformis Live Bacteria Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Northeast Pharmaceutical Group Bacillus Licheniformis Live Bacteria Capsule Product Portfolio
- 4.3.5 Northeast Pharmaceutical Group Recent Developments
- 4.4 Novonesis
- 4.4.1 Novonesis Company Information
- 4.4.2 Novonesis Business Overview
- 4.4.3 Novonesis Bacillus Licheniformis Live Bacteria Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novonesis Bacillus Licheniformis Live Bacteria Capsule Product Portfolio
- 4.4.5 Novonesis Recent Developments
- 4.5 Hanmi Pharmaceutical
- 4.5.1 Hanmi Pharmaceutical Company Information
- 4.5.2 Hanmi Pharmaceutical Business Overview
- 4.5.3 Hanmi Pharmaceutical Bacillus Licheniformis Live Bacteria Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hanmi Pharmaceutical Bacillus Licheniformis Live Bacteria Capsule Product Portfolio
- 4.5.5 Hanmi Pharmaceutical Recent Developments
- 4.6 BMI KOREA
- 4.6.1 BMI KOREA Company Information
- 4.6.2 BMI KOREA Business Overview
- 4.6.3 BMI KOREA Bacillus Licheniformis Live Bacteria Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BMI KOREA Bacillus Licheniformis Live Bacteria Capsule Product Portfolio
- 4.6.5 BMI KOREA Recent Developments
5 Global Bacillus Licheniformis Live Bacteria Capsule Market Scenario by Region
- 5.1 Global Bacillus Licheniformis Live Bacteria Capsule Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bacillus Licheniformis Live Bacteria Capsule Sales by Region: 2021-2032
- 5.2.1 Global Bacillus Licheniformis Live Bacteria Capsule Sales by Region: 2021-2026
- 5.2.2 Global Bacillus Licheniformis Live Bacteria Capsule Sales by Region: 2027-2032
- 5.3 Global Bacillus Licheniformis Live Bacteria Capsule Revenue by Region: 2021-2032
- 5.3.1 Global Bacillus Licheniformis Live Bacteria Capsule Revenue by Region: 2021-2026
- 5.3.2 Global Bacillus Licheniformis Live Bacteria Capsule Revenue by Region: 2027-2032
- 5.4 North America Bacillus Licheniformis Live Bacteria Capsule Market Facts & Figures by Country
- 5.4.1 North America Bacillus Licheniformis Live Bacteria Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bacillus Licheniformis Live Bacteria Capsule Sales by Country (2021-2032)
- 5.4.3 North America Bacillus Licheniformis Live Bacteria Capsule Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bacillus Licheniformis Live Bacteria Capsule Market Facts & Figures by Country
- 5.5.1 Europe Bacillus Licheniformis Live Bacteria Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bacillus Licheniformis Live Bacteria Capsule Sales by Country (2021-2032)
- 5.5.3 Europe Bacillus Licheniformis Live Bacteria Capsule Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bacillus Licheniformis Live Bacteria Capsule Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bacillus Licheniformis Live Bacteria Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bacillus Licheniformis Live Bacteria Capsule Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bacillus Licheniformis Live Bacteria Capsule Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bacillus Licheniformis Live Bacteria Capsule Market Facts & Figures by Country
- 5.7.1 South America Bacillus Licheniformis Live Bacteria Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bacillus Licheniformis Live Bacteria Capsule Sales by Country (2021-2032)
- 5.7.3 South America Bacillus Licheniformis Live Bacteria Capsule Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bacillus Licheniformis Live Bacteria Capsule Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bacillus Licheniformis Live Bacteria Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bacillus Licheniformis Live Bacteria Capsule Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bacillus Licheniformis Live Bacteria Capsule Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bacillus Licheniformis Live Bacteria Capsule Sales by Type (2021-2032)
- 6.1.1 Global Bacillus Licheniformis Live Bacteria Capsule Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Bacillus Licheniformis Live Bacteria Capsule Sales Market Share by Type (2021-2032)
- 6.2 Global Bacillus Licheniformis Live Bacteria Capsule Revenue by Type (2021-2032)
- 6.2.1 Global Bacillus Licheniformis Live Bacteria Capsule Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bacillus Licheniformis Live Bacteria Capsule Revenue Market Share by Type (2021-2032)
- 6.3 Global Bacillus Licheniformis Live Bacteria Capsule Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bacillus Licheniformis Live Bacteria Capsule Sales by Application (2021-2032)
- 7.1.1 Global Bacillus Licheniformis Live Bacteria Capsule Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Bacillus Licheniformis Live Bacteria Capsule Sales Market Share by Application (2021-2032)
- 7.2 Global Bacillus Licheniformis Live Bacteria Capsule Revenue by Application (2021-2032)
- 7.2.1 Global Bacillus Licheniformis Live Bacteria Capsule Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bacillus Licheniformis Live Bacteria Capsule Revenue Market Share by Application (2021-2032)
- 7.3 Global Bacillus Licheniformis Live Bacteria Capsule Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bacillus Licheniformis Live Bacteria Capsule Value Chain Analysis
- 8.1.1 Bacillus Licheniformis Live Bacteria Capsule Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bacillus Licheniformis Live Bacteria Capsule Production Mode & Process
- 8.2 Bacillus Licheniformis Live Bacteria Capsule Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bacillus Licheniformis Live Bacteria Capsule Distributors
- 8.2.3 Bacillus Licheniformis Live Bacteria Capsule Customers
9 Global Bacillus Licheniformis Live Bacteria Capsule Analyzing Market Dynamics
- 9.1 Bacillus Licheniformis Live Bacteria Capsule Industry Trends
- 9.2 Bacillus Licheniformis Live Bacteria Capsule Industry Drivers
- 9.3 Bacillus Licheniformis Live Bacteria Capsule Industry Opportunities and Challenges
- 9.4 Bacillus Licheniformis Live Bacteria Capsule Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst